|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0045093,
umls-concept:C0078257,
umls-concept:C0205179,
umls-concept:C0205390,
umls-concept:C0331865,
umls-concept:C0337810,
umls-concept:C0441655,
umls-concept:C0600688,
umls-concept:C0684249,
umls-concept:C1511726,
umls-concept:C2603343
|
|
pubmed:issue |
2-3
|
|
pubmed:dateCreated |
2001-2-22
|
|
pubmed:abstractText |
Following the demonstration that vinorelbine improves survival and quality of life compared with best supportive care in elderly patients with advanced non-small-cell lung cancer (NSCLC), we started the three-arm prospective Multicenter Italian Lung Cancer in the Elderly Study (MILES) trial of vinorelbine, gemcitabine and gemcitabine + vinorelbine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
pubmed-author:AdamsRR,
pubmed-author:CigolariSS,
pubmed-author:FerrelWW,
pubmed-author:FrontiniLL,
pubmed-author:GalloCC,
pubmed-author:GaspariniGG,
pubmed-author:GridelliCC,
pubmed-author:IannielloG PGP,
pubmed-author:MILES Investigators,
pubmed-author:ManzioneLL,
pubmed-author:NovelloSS,
pubmed-author:PerroneFF,
pubmed-author:RobbiatiS FSF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
277-84
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11165408-Age Factors,
pubmed-meshheading:11165408-Aged,
pubmed-meshheading:11165408-Antimetabolites, Antineoplastic,
pubmed-meshheading:11165408-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:11165408-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11165408-Atrial Fibrillation,
pubmed-meshheading:11165408-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11165408-Deoxycytidine,
pubmed-meshheading:11165408-Drug-Induced Liver Injury,
pubmed-meshheading:11165408-Female,
pubmed-meshheading:11165408-Fever,
pubmed-meshheading:11165408-Humans,
pubmed-meshheading:11165408-Infusions, Intravenous,
pubmed-meshheading:11165408-Lung Neoplasms,
pubmed-meshheading:11165408-Male,
pubmed-meshheading:11165408-Neutropenia,
pubmed-meshheading:11165408-Thrombocytopenia,
pubmed-meshheading:11165408-Vinblastine
|
|
pubmed:articleTitle |
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
|
|
pubmed:affiliation |
Divisione di Oncologioca Medica B, Istituto Nazionale per lo Studio e la Cura dei Tumori, via M. Semmola, 80131 Naples, Italy. cgridelli@sirio-oncology.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|
